Posters
Quality of life patient questionnaire after refractive lenticule extraction (ReLEx) SMILE: comparison of the first and last consecutive cases
Poster Details
First Author: T.Ax GERMANY
Co Author(s): D. Breyer H. Kaymak K. Klabe P. Hagen F. Kretz G. Auffarth
Abstract Details
Purpose:
The aim of this retrospective data analysis was to compare the quality of life and vision of our first and last consecutive patients treated with bilateral ReLEx SMILE. This way we investigated the question whether the treatment related learning curve and improvements in laser spot energy settings are reflected in our patients�� postoperative quality of life and vision.
Setting:
All ReLEx SMILE (VisuMax, CZM) treatments and follow-ups were performed at the Breyer-Kaymak-Klabe Eyesurgery in Duesseldorf, Germany. We considered two groups of patients that underwent bilateral ReLEx SMILE:Group A: Our first 32 consecutive cases (begin: 01-Feb-2012),Group B: Our last 32 consecutive cases (begin: 01-Feb-2016).
Methods:
Visual acuity at far and manifest refraction were measured with a phoropter and ETDRS reading charts in 4m distance. Furthermore, 3 month after the second surgery the postoperative quality of life was assessed using a ��The Quality of Life Impact of Refractive Correction (QIRC)�� patient questionnaire (Pesudovs et. al 2004). Thereby we used a german translation which was translated back to English by a professional translation company and then compared to the original version in order to check for consistency. Patient answers for the 5-category response scale were converted into Rasch scaled scores.
Results:
The mean score of group A (B) for the questions �â��1: How much difficulty do you have driving in glare conditions?�â��, �â��9: How concerned are you about the cost of unscheduled maintenance of your refractive surgery?�â��, and the total score were 53�Â�±11 (54�Â�±9), 56�Â�±10 (59�Â�±5), and 51�Â�±5 (51�Â�±4), respectively.
Conclusions:
Our evaluation did not display significant differences between both patient groups and the scoring numbers were in agreement with literature values. In total the patients were very satisfied with the ReLEx SMILE treatment.
Financial Disclosure:
receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company
